(IQV) – Press Releases
-
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
-
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
-
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
-
IQVIA Publishes its 2023 Environmental, Social and Governance Report
-
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
-
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
-
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
-
IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year
-
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
-
Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report
-
IQVIA Digital Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year
-
IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
-
IQVIA Announces Upsizing of its Allocation of New Term B Loans
-
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes
-
IQVIA Announces Offering of Senior Secured Notes
-
IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree
-
IQVIA Reports Third-Quarter 2023 Results
-
IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East
-
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
-
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
-
Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science
-
IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
-
IQVIA Appoints Richard Staub III President of Research & Development Solutions
-
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
-
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
-
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
-
IQVIA Reports Second-Quarter 2023 Results
-
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
-
IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award
-
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
-
IQVIA Wins Prestigious “Best AI-based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
-
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management
-
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
-
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
-
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
-
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
-
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
-
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
-
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
-
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
-
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
-
Florence Healthcare Now Equipping IQVIA Research Sites With Site Enablement Technology
-
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
-
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
-
IQVIA Publishes its 2022 Environmental, Social and Governance Report
-
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
-
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
-
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
-
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
-
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
Back to IQV Stock Lookup
